Breaking News Instant updates and real-time market news.

SYNA

Synaptics

$45.96

-0.09 (-0.20%)

, AAPL

Apple

$219.75

1.78 (0.82%)

08:54
08/29/18
08/29
08:54
08/29/18
08:54

Synaptics in early innings of multi-product upgrade cycle, says Craig-Hallum

Craig-Hallum analyst Anthony Stoss says that based on his checks, most of Synaptics' (SYNA) China based customers are changing up already planned designs for 2019 from CoG to LCD CoF, which is a more expensive solution from the company. The analyst notes that CoF enables full screen infinity displays, a design element Apple (AAPL) is expected to use on all three of its upcoming models. He believes Apple will be using Synaptics' CoF for its LCD model, and thinks the latter is in the early innings of a multi-product refresh/upgrade cycle. Stoss reiterates a Buy rating and $56 price target on Synaptics shares.

SYNA

Synaptics

$45.96

-0.09 (-0.20%)

AAPL

Apple

$219.75

1.78 (0.82%)

  • 12

    Sep

SYNA Synaptics
$45.96

-0.09 (-0.20%)

08/01/18
08/01/18
UPGRADE
Target $51

Buy
Synaptics upgraded to Buy after deal talks end at Craig-Hallum
As previously reported, Craig-Hallum analyst Anthony Stoss upgraded Synaptics (SYNA) to Buy from Hold, with a $51 price target, after the company confirmed that it has terminated buyout discussions with Dialog Semiconductor (DLGNF). The analyst notes that he never believed the Dialog Semiconductor deal would happen, and thinks the risk reward tilts back in favor of owning shares.
08/10/18
NEED
08/10/18
NO CHANGE
Target $58
NEED
Buy
Synaptics price target raised to $58 from $52 at Needham
Needham analyst Rajvindra Gill raised his price target on Synaptics to $58 after its Q4 earnings beat and guidance, saying he expects the company to benefit from a higher gross margin profile in FY19 as well as higher average selling prices across its portfolio. The analyst keeps his Buy rating on Synaptics, anticipating the company to be a major supplier amid the rising OLED touch revenues in China with new panel capacity coming online in 2019.
08/10/18
CHLM
08/10/18
NO CHANGE
Target $56
CHLM
Buy
Synaptics price target raised to $56 from $51 at Craig-Hallum
Craig-Hallum analyst Anthony Stoss reiterated a Buy rating on Synaptics and raised his price target to $56 from $51 after the company reported results in-line with expectations, with September guidance below estimates. Stoss points out that Synaptics guided FY19 revenues to grow low-single-digits which was below estimates, due to the decision to walk away from the expected low margin optical fingerprint business and a shortage in capacity for TDDI materials, but notes that this will actually bode well for the company's mix over time as they are walking away from lower margin business, and should meaningfully grow EPS in 2019 despite slower revenue growth.
08/10/18
LSCM
08/10/18
NO CHANGE
Target $52
LSCM
Hold
Synaptics price target raised to $52 from $42 at Lake Street
Lake Street analyst Jaeson Schmidt raised his price target for Synaptics to $52 but maintains a Hold rating on the shares following the company's Q2 results. Mobile shortages continue to create near-term headwinds for Synaptics, Schmidt tells investors in a post-earnings research note.
AAPL Apple
$219.75

1.78 (0.82%)

08/23/18
08/23/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. ROSENBLATT BOOSTS AMD PRICE TARGET TO STREET HIGH: Rosenblatt analyst Hans Mosesmann raised his price target for AMD (AMD) shares to $30 from $27. Mosesmann's new price target represents the high among Wall Street sell-side analysts. Following the meetings, Mosesmann has renewed conviction in AMD's multi-year double digit growth profile. Further, he's impressed by the analysis investors are doing in the name after years of disregard. AMD is up 4.1% in late morning trading. CANTOR CUTS AETNA TO NEUTRAL: Cantor Fitzgerald analyst Steven Halper downgraded Aetna (AET) to Neutral from Overweight with a price target of $202. The stock now trades at just a 4.6% discount to the implied CVS Health (CVS) acquisition value of about $207 per share, Halper said. He believes the narrowed deal spread reflects an increased likelihood of regulatory approval. Halper cites limited potential upside for his downgrade of Aetna to Neutral. NIELSEN UPGRADED TO NEUTRAL AT GOLDMAN: Goldman Sachs analyst George Tong upgraded Nielsen Holdings (NLSN) to Neutral and raised his price target for the shares to $25 from $20. With activist Elliott Management pushing for a sale and increased deal activity in the Information Services sector, Tong sees increased likelihood of Nielsen being involved in a transaction. His upgrade to Neutral and price target increase come after the analyst incorporated a potential takeover into his model. Nielsen is up 3.3% in late morning trading. IMPERIAL SEES SUBSCRIBER UPSIDE FOR NETFLIX: Imperial Capital analyst David Miller believes Netflix's (NFLX) experiment with ending billing through Apple's (AAPL) app store in 33 countries outside the U.S. likely implies upside to its Q3 international subscriber guidance. The analyst said he has a tough time believing that Netflix would "experiment" with billing infrastructure mid-quarter if it did not believe that its international subscriber levels were trending ahead of guidance. As such, Miller raised his Q3 international subscriber estimate to 4.46M from 4.35M. He kept an Outperform rating on Netflix with a $494 price target. TARGET GETS UPGRADE AND DOWNGRADE: Target (TGT) was upgraded to Outperform from Market Perform at Telsey Advisory, and downgraded to Peer Perform from Outperform at Wolfe Research.
08/24/18
BARD
08/24/18
NO CHANGE
Target $99
BARD
Outperform
Baird raises PayPal price target to $99 on favorable Venmo outlook
Baird analyst Colin Sebastian raised his price target for PayPal (PYPL) to $99 from $96 to reflect a favorable view of Venmo's monetization opportunity. The shares closed yesterday up 43c to $87.38. A survey of 1,500 Internet users spotlights PayPal as the "clear and dominant digital wallet," and serves as a positive leading indicator for "Pay with Venmo" adoption, Sebastian tells investors in a research note titled "Beyond the Pizza Emoji: Assessing Venmo's Profit Potential." He believes Venmo may be approaching native wallet levels like Apple's (AAPL) ApplePay. While still early, PayPal's dual-brand strategy could reasonably contribute $150M-$300M incrementally to 2021 operating profit and potentially more, Sebastian contends. He believes Venmo is on track to become a billion-dollar business. Sebastian says that while Venmo may not fully replace the lost contribution profit from eBay (EBAY), investors are likely to put a premium on Venmo-generated incremental revenues. The analyst envisions Vevmo generating $2.5B in revenue and $1.3B in EBITDA by 2025. Sebastian upped his 2020 earnings per share estimate for PayPal to $3.36 from $3.20 and keeps an Outperform rating on the shares.
08/27/18
RBCM
08/27/18
NO CHANGE
Target $225
RBCM
Outperform
Apple unlikely to be hit by apps' potential bypass of fees, says RBC Capital
RBC Capital analyst Amit Daryanani writes that Netflix (NFLX) is testing an "experimental feature" that would allow its users to bypass Apple (AAPL) signup fees in certain international markets - a tactic already used by Spotify (SPOT) - which could lead to Apple being cut out of its 30% initial /15% renewal cut of the fees. The analyst notes however that the AppStore prohitibs apps from implementing alternate payment mechanisms, and even if the apps bypass was successful, "most users of Netflix and other apps have already signed up in past through App Store and Apple would continue to collect payments on that large user base." Daryanani keeps his Outperform rating and $225 price target on Apple.
08/27/18
BARD
08/27/18
NO CHANGE
BARD
Outperform
Apple market share remains at recent highs, says Baird
Baird analyst William Power said his Apple survey shows its market share remains at recent highs despite smartphone purchase intention remaining below its historical average. The analyst believes Apple's market share suggests further share gains supplemented by strong sales of other Apple devices and rising services usage. Power reiterated his Outperform rating on Apple shares and said it remains a top big-cap idea.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$305.52

4.47 (1.48%)

10:17
09/26/18
09/26
10:17
09/26/18
10:17
Periodicals
Trucking industry disputes Musk's shortage claims for delivery delays, LAT says »

The trucking industry is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 29

    Oct

  • 13

    Nov

SVMK

SurveyMonkey

$0.00

(0.00%)

10:17
09/26/18
09/26
10:17
09/26/18
10:17
Syndicate
Breaking Syndicate news story on SurveyMonkey »

SurveyMonkey indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
09/26/18
09/26
10:17
09/26/18
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KBH

KB Home

$24.69

-0.6 (-2.37%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
Technical Take: KB Home reverses sharply lower after housing data »

The stock had been up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
09/26/18
09/26
10:16
09/26/18
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBM

IBM

$151.89

2.98 (2.00%)

10:15
09/26/18
09/26
10:15
09/26/18
10:15
Hot Stocks
IBM rises after UBS says buy on AI potential, low public cloud exposure »

In a research note to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 22

    Oct

  • 03

    Mar

10:15
09/26/18
09/26
10:15
09/26/18
10:15
General news
Breaking General news story  »

Week of 9/21 EIA…

SVMK

SurveyMonkey

$0.00

(0.00%)

10:13
09/26/18
09/26
10:13
09/26/18
10:13
Syndicate
SurveyMonkey indicated to open at $20, IPO priced at $12 »

SurveyMonkey (SVMK)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BBVA

Banco Bilbao

$6.55

-0.035 (-0.53%)

10:12
09/26/18
09/26
10:12
09/26/18
10:12
Hot Stocks
Banco Bilbao designates CEO Carlos Torres Vila as next chairman »

The board BBVA approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

F

Ford

$9.37

-0.025 (-0.27%)

, VLKAY

Volkswagen

$0.00

(0.00%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Periodicals
Ford expands partnership talks with VW, Mahindra to cut costs, Reuters reports »

Ford (F) CEO Jim Hackett…

F

Ford

$9.37

-0.025 (-0.27%)

VLKAY

Volkswagen

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 02

    Oct

SQ

Square

$94.76

-0.64 (-0.67%)

10:10
09/26/18
09/26
10:10
09/26/18
10:10
Options
Heavy trading in Square weekly options as shares fall from record highs »

Heavy trading in Square…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 26

    Nov

ETTX

Entasis Therapeutics

$0.00

(0.00%)

10:03
09/26/18
09/26
10:03
09/26/18
10:03
Syndicate
Entasis Therapeutics opens at $13.45, IPO priced at $15.00 per share »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WOR

Worthington

$42.88

-3.39 (-7.33%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Worthington falls -7.4% »

Worthington is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Options
Active trading in GoPro weekly options as shares spike »

Active trading in GoPro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATU

Actuant

$27.10

-2.65 (-8.91%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Actuant falls -7.9% »

Actuant is down -7.9%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

PES

Pioneer Energy

$3.13

-0.325 (-9.42%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Pioneer Energy falls -8.1% »

Pioneer Energy is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BFR

BBVA Banco Frances

$12.83

0.63 (5.16%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
BBVA Banco Frances rises 5.4% »

BBVA Banco Frances is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IRS

Irsa Inversiones y Representaciones SA

$18.00

1.18 (7.02%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Irsa Inversiones y Representaciones SA rises 7.3% »

Irsa Inversiones y…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IBD

Care Concepts I, Inc.

$24.22

(0.00%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
Care Concepts I, Inc. rises 6.6% »

Care Concepts I, Inc. is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GPRO

GoPro

$7.25

0.62 (9.35%)

10:00
09/26/18
09/26
10:00
09/26/18
10:00
Hot Stocks
GoPro rises following analyst upgrade on 'compelling' products »

Shares of GoPro (GPRO)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

, AMC

AMC Entertainment

$20.05

0.175 (0.88%)

09:56
09/26/18
09/26
09:56
09/26/18
09:56
Hot Stocks
Helios and Matheson sinks as AMC's Stubs A-List surpasses 380,000 members »

Shares of MoviePass…

HMNY

Helios and Matheson

$0.02

-0.0015 (-8.06%)

AMC

AMC Entertainment

$20.05

0.175 (0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 13

    Nov

SCG

Scana

$36.25

0.96 (2.72%)

, ALXN

Alexion

$134.40

5.4 (4.19%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Options
Early notable gainers among liquid option names on September 26th »

Notable gainers among…

SCG

Scana

$36.25

0.96 (2.72%)

ALXN

Alexion

$134.40

5.4 (4.19%)

VIAB

Viacom

$33.80

1.32 (4.06%)

NLSN

Nielsen

$28.00

0.795 (2.92%)

GE

General Electric

$11.42

0.15 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 18

    Feb

ABBV

AbbVie

$94.50

0.72 (0.77%)

, VRTX

Vertex

$184.11

1.54 (0.84%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
William Blair biotech analysts to hold an analyst/industry conference call »

Biotech Analysts Xu,…

ABBV

AbbVie

$94.50

0.72 (0.77%)

VRTX

Vertex

$184.11

1.54 (0.84%)

ACER

Acer Therapeutics

$30.55

(0.00%)

BHVN

Biohaven Pharmaceutical

$37.47

(0.00%)

CELG

Celgene

$88.38

0.82 (0.94%)

EXEL

Exelixis

$17.38

0.19 (1.11%)

PTLA

Portola Pharmaceuticals

$28.27

0.57 (2.06%)

BMY

Bristol-Myers

$62.20

0.38 (0.61%)

BIIB

Biogen

$342.79

1.21 (0.35%)

AMGN

Amgen

$208.06

1.59 (0.77%)

BLUE

Bluebird Bio

$141.90

(0.00%)

ONCE

Spark Therapeutics

$57.63

0.07 (0.12%)

LOXO

Loxo Oncology

$164.55

-2.25 (-1.35%)

RCKT

Rocket Pharmaceuticals

$25.11

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 26

    Sep

  • 01

    Oct

  • 03

    Oct

  • 04

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

  • 29

    Oct

  • 09

    Nov

  • 26

    Nov

  • 27

    Nov

  • 01

    Dec

  • 31

    Dec

  • 14

    Jan

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

KO

Coca-Cola

$45.79

0.105 (0.23%)

09:55
09/26/18
09/26
09:55
09/26/18
09:55
Conference/Events
Senate Environment and Public Works Committee to hold a hearing »

The Committee holds a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 30

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.